Home Cart Sign in  
Chemical Structure| 1435488-37-1 Chemical Structure| 1435488-37-1

Structure of XMD17-109
CAS No.: 1435488-37-1

Chemical Structure| 1435488-37-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

XMD17-109 is a specific ERK-5 inhibitor with an EC50 4.2 μM in HEK293 cells.

Synonyms: ERK5-IN-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of XMD17-109

CAS No. :1435488-37-1
Formula : C36H46N8O3
M.W : 638.80
SMILES Code : O=C1C2=C(C=CC=C2)N(C3CCCC3)C4=NC(NC5=C(OCC)C=C(C(N6CCC(N7CCN(C)CC7)CC6)=O)C=C5)=NC=C4N1C
Synonyms :
ERK5-IN-1
MDL No. :MFCD26142929
InChI Key :XVBGRTMNFNMINE-UHFFFAOYSA-N
Pubchem ID :71604307

Safety of XMD17-109

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of XMD17-109

MAPK

Isoform Comparison

Biological Activity

Target
  • ERK5

    ERK5, IC50:162 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Aiptasia larvae 1 μM 1 h Inhibition of ERK5 activity reduced the retention of symbionts in host cells and increased the expulsion of symbionts. PMC7611106
J774.A1 cells 1 µM 18 h Inhibition of ERK5 activity significantly increased vomocytosis rates in J774.A1 cells. PMC5559206
Human PBMC-derived macrophages 1 µM 18 h Inhibition of ERK5 activity significantly increased vomocytosis rates in human PBMC-derived macrophages. PMC5559206
HMVEC-lung cells 1 μM 6 h Inhibited the secretion of IL-6 and IL-8, indicating the role of ERK5 in inflammatory responses PMC5734625
HUVECs 1 μM 6 h Inhibited the secretion of IL-6 and IL-8, indicating the role of ERK5 in inflammatory responses PMC5734625
PBMCs 1 μM 6 h Inhibited the secretion of IL-6 and IL-8, indicating the role of ERK5 in inflammatory responses PMC5734625
monocytes 1 μM 6 h Inhibited the secretion of IL-6 and IL-8, indicating the role of ERK5 in inflammatory responses PMC5734625

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice LPS-induced endotoxemia model intraperitoneal injection 50 mg/kg Single dose, monitored for up to 72 hours Inhibition of ERK5 activity significantly improved survival rates in mice PMC5734625

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.57mL

0.31mL

0.16mL

7.83mL

1.57mL

0.78mL

15.65mL

3.13mL

1.57mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories